Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of Mycobacterium vaccae injection as adjunctive therapy for asthma
ChiCTR-TRC-08000051Phase 3Completed
- Sponsor
- Shanghai Changzheng Hospital
- Start
- Jan 2008
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of mycobacterium vaccae in asthma (2 arms), sponsored by Shanghai Changzheng Hospital. Primary endpoint: Incidence rate of asthma aggravation. Started Jan 2008; status: completed.
02
Drugs
mycobacterium vaccae
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR-TRC-08000051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000051.